Revenue Performance - Natural Beauty Bio-Technology Limited reported a significant increase in revenue, achieving a total of HKD 150 million, representing a 25% growth compared to the previous year[15]. - The Group's turnover decreased by 29.1% to HK$163.6 million for the six months ended 30 June 2022, down from HK$230.9 million in the same period of 2021[20]. - Revenue for the six months ended June 30, 2022, was HK$163,591,000, a decrease of 29% compared to HK$230,878,000 in the same period of 2021[175]. - Revenue from the PRC market was HK$97,767,000, down 25% from HK$131,236,000 year-on-year[175]. - Revenue from Taiwan decreased by 38% to HK$60,004,000 compared to HK$97,414,000 in 2021[175]. Customer Engagement and Market Expansion - The company expanded its user base, reaching 200,000 active customers, which is a 15% increase year-over-year[15]. - The company plans to enter two new markets in Southeast Asia by the end of 2023, aiming to capture an additional 10% market share in the region[15]. - A strategic acquisition of a local beauty brand is anticipated to enhance product offerings and customer reach, expected to be finalized by Q4 2023[15]. - The company is exploring partnerships with e-commerce platforms to enhance online sales, targeting a 50% increase in digital revenue[15]. Financial Performance and Profitability - The overall gross profit margin decreased from 63.1% to 53.5% due to changes in product revenue mix and COVID-related policies[19]. - The profit for the period decreased by 277.6%, resulting in a loss of HK$30.2 million compared to a profit of HK$17.0 million for the six months ended June 30, 2021[44]. - The company reported a loss before tax of HK$25.3 million, a decrease of 200.1% from a profit of HK$25.2 million for the same period in 2021[44]. - The company reported a total comprehensive loss for the period amounted to HK$63,734,000, compared to a comprehensive income of HK$24,507,000 in the prior year[131]. Research and Development - Investment in research and development increased by 20%, focusing on innovative beauty products and sustainable technologies[15]. - The R&D team consists of over ten researchers and collaborates with professional laboratories in Europe, Japan, and Australia to develop new products and technologies[61]. - The Group has obtained several patents, including stem cell patents and a plant extraction patent, and plans to actively deploy patents related to plant extraction in response to market trends[61]. Operational Efficiency and Cost Management - Total administrative expenses decreased by HK$6.4 million or 15.1% to HK$35.9 million for the six months ended 30 June 2022, compared to HK$42.3 million for the same period last year[36]. - Selling expenses decreased by HK$11.5 million to HK$6.5 million for the six months ended 30 June 2022, down from HK$18.0 million for the same period last year[34]. - The company is focusing on improving operational efficiency and exploring new market opportunities to enhance future performance[131]. Corporate Governance - The company has established various committees, including the Audit Committee and Remuneration Committee, to ensure high standards of corporate governance[80]. - The company has fully complied with all code provisions set out in the Corporate Governance Code throughout the six months ended June 30, 2022[92]. - The Audit Committee has confirmed that adequate disclosures have been made in the financial statements for the first half of 2022[82]. Shareholder Information - As of June 30, 2022, Eastern Media International Corporation and its subsidiary hold a substantial interest of 600,630,280 ordinary shares, representing approximately 30.00% of the issued share capital of the Company[115]. - CHAO Shih-Heng and associated entities hold 455,630,196 ordinary shares, accounting for approximately 22.76% of the Company's issued share capital[115]. - The Company declared a final dividend of HK$0.003 per share, totaling approximately HK$6,006,000, consistent with the previous year[190].
自然美(00157) - 2022 - 中期财报